Summit Trail Advisors, LLC Bristol Myers Squibb CO Transaction History

Summit Trail Advisors, LLC

  • $7.06 Billion
  • Q3 2025

A detailed history of Summit Trail Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 61,235 shares of BMY stock, worth $2.87 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
61,235
Previous 61,557 0.52%
Holding current value
$2.87 Million
Previous $2.85 Million 3.09%
% of portfolio
0.04%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$43.31 - $48.98 $13,945 - $15,771
-322 Reduced 0.52%
61,235 $2.76 Million
Q2 2025

Aug 14, 2025
BUY
$44.12 - $59.6 $2.72 Million - $3.67 Million
61,557 New
61,557 $2.85 Million
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $35,456 - $46,264
894 Added 1.84%
49,473 $2.56 Million
Q2 2024

Aug 13, 2024
BUY
$40.25 - $52.99 $1.3 Million - $1.71 Million
32,236 Added 197.25%
48,579 $2.02 Million
Q1 2024

Apr 23, 2024
BUY
$47.98 - $54.4 $226,321 - $256,604
4,717 Added 40.57%
16,343 $886,000
Q4 2023

Feb 06, 2024
SELL
$48.48 - $57.85 $85,567 - $102,105
-1,765 Reduced 13.18%
11,626 $596,000
Q3 2023

Oct 30, 2023
SELL
$57.89 - $64.73 $138,299 - $154,639
-2,389 Reduced 15.14%
13,391 $777,000
Q2 2023

Jul 25, 2023
BUY
$63.71 - $70.74 $322,627 - $358,227
5,064 Added 47.26%
15,780 $1.01 Million
Q1 2023

May 04, 2023
BUY
$65.71 - $74.53 $337,486 - $382,786
5,136 Added 92.04%
10,716 $742,000
Q4 2022

Feb 07, 2023
SELL
$68.48 - $81.09 $39,923 - $47,275
-583 Reduced 9.46%
5,580 $401,000
Q3 2022

Nov 09, 2022
BUY
$0.13 - $76.84 $142 - $84,370
1,098 Added 21.68%
6,163 $438,000
Q2 2022

Aug 09, 2022
BUY
$72.62 - $79.98 $133,766 - $147,323
1,842 Added 57.15%
5,065 $393,000
Q1 2022

May 16, 2022
BUY
$61.48 - $73.72 $198,150 - $237,599
3,223 New
3,223 $237,000
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $235,925 - $267,346
-4,086 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $234,658 - $260,033
4,086 New
4,086 $256,000
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $389,586 - $485,575
-7,710 Closed
0 $0
Q1 2018

May 22, 2018
SELL
$59.92 - $68.98 $16.2 Million - $18.7 Million
-271,129 Reduced 97.23%
7,710 $279,000
Q1 2018

May 21, 2018
BUY
$59.92 - $68.98 $16.2 Million - $18.7 Million
270,884 Added 3405.2%
278,839 $279,000
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $476,822 - $519,859
7,955
7,955 $503,000

Others Institutions Holding BMY

# of Institutions
2,680
Shares Held
1.58B
Call Options Held
28M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email